The Mitochondrion in Aging and Disease (Volume 127) (Progress in Molecular Biology and Translational Science, Volume 127)
Original price was: $160.61.$94.48Current price is: $94.48.
9780123946256, Academic Press, H.D., Osiewacz
Original price was: $160.61.$94.48Current price is: $94.48.
Adobooks Marketplace
Related Products
![ATI TEAS 7 Study Guide 2023-2024: 4 Practice Exams and TEAS Test Review Book for Nursing Entrance [2nd Edition] ISBN-13: 9781637753033](https://www.adobooks.com/wp-content/uploads/2025/11/51EffQg4tsL_ac91834e-0c3f-425e-b049-d7ec8615bb0c-300x300.jpg)
![CEN Exam Secrets Study Guide – CEN Review Book for the Certified Emergency Nurse Exam, Full-Length Practice Test, Step-by-Step Review Video Tutorials: [3rd Edition] (Mometrix Test Preparation) ISBN-13: 9781516713103](https://www.adobooks.com/wp-content/uploads/2025/11/51l6giDMxjL-300x300.jpg)
Author: Osiewacz, H.D.
Brand: Academic Press
Edition: 1
ISBN: 9780123946256
Release Date: 11-09-2014
Package Dimensions: 9.1 x 6.1 x 0.8 inches
Languages: English
Binding: hardcover
Number Of Pages: 290
Details: Mitochondria, the “power plants” of eukaryotic cells, are best known for the generation of adenosine triphosphate (ATP), the universal cellular “energy currency” of the cell, and the synthesis of different essential components. Mitochondrial dysfunction is known to lead to various degenerative disorders, disease, and aging. The Mitochondrion in Aging and Disease works to unravel the processes leading to mitochondrial impairments and of pathways involved in mitochondrial quality control and their impact on health and aging will be addressed. Reviews current topics of interest Written by experts in the field
User Reviews
Be the first to review “The Mitochondrion in Aging and Disease (Volume 127) (Progress in Molecular Biology and Translational Science, Volume 127)”
Vendor Information
- Store Name: Adobooks Marketplace
- Vendor: Adobooks Marketplace
- 4.71 rating from 7 reviews
Original price was: $160.61.$94.48Current price is: $94.48.
There are no reviews yet.